Rev Neurol France
-
This study evaluates comorbidities, primary and secondary drug prevention and two years survival among patients hospitalized for stroke during the first half of 2008. ⋯ These patients presented frequently a history of stroke and comorbidities and their level of secondary prevention must be improved.